Archive · 27 Nov 2025
Anti-Ageing Drug For Dogs Could Debut In 2026
Scientists are working on a special pill called LOY-002 that might help older dogs live healthier and longer.
This pill is made by a company called Loyal and has been approved by a big health organization in the U.S. called the FDA.
The pill works like a diet that helps dogs stay healthy without eating less.
It's being tested on dogs that are 10 years or older and weigh at least 14 pounds.
Many people are excited about this because they want their dogs to live longer and stay happy.
The company hopes to sell the pill in 2026 if everything goes well.
LOY-002, an anti-ageing drug for senior dogs, is in development by Loyal and could be available by 2026.
The drug has received FDA acceptance for a 'reasonable expectation of efficacy' (RXE).
LOY-002 is a caloric-restriction mimetic, mimicking the benefits of a calorie-controlled diet without reducing food intake.
The drug is designed for dogs aged 10 and older, weighing at least 14 pounds.
Early studies showed no adverse effects after three months of treatment in 48 dogs.
- Who
- Loyal, a veterinary biotechnology company
- What
- Development of an anti-ageing drug for senior dogs
- When
- Expected market release in 2026
- Where
- United States, backed by the FDA
- Why
- To extend the healthy lifespan of dogs
- Drug Name
- LOY-002
- Developer
- Loyal
- FDA Milestone
- Reasonable Expectation of Efficacy (RXE)
- Target Age
- 10 and older
- Target Weight
- At least 14 pounds
- Expected Market Release
- 2026
- Drug Type
- Caloric-restriction mimetic